BRN (ASX) Contrarian views

Originally posted by shareman: ↑

The recent events on HotCopper where BRN bulls were triggered into meltdown by a single article that raised some issues only serves to reinforce some of the views below.

As I have posted previously, for those who are brave enough to take ared pill:

- In my opinion, BRN is still a very high-risk play due to the fast-changing and ferociously competitive sector it operates in. It may well succeed (which would be great), but the chances are still reasonably low and they have their work cut out for them. If you would not bet the amount of money you have invested in BRN on a horse with a significant chance of failure, it might be wise to at least reflect on whether you may have invested more than you can afford to lose

- At this stage we just don’t know whether the Akida technology is mature and robust enough for it to be a commercial success, or whether it will end up as just a hobbyist’s toy. Only time will tell.

- There is enormous competition out there from all sorts of architectures. Despite what BRN bulls might try and convince you of, a competitor to Akida does NOT need to be another neuromorphic chip. It can be ANY architecture that satisfies the customer's needs.

- Many posters here seem to claim Akida will be placed in almost every product that exists and the only reason we have not heard about it is because it is subject to an NDA. Of course, this exact same logic could also be applied to every one of the many competitors to Akida that exist, and similarly it could be argued they have all entered into many agreements subject to an NDA too

- The reality is 99% of the times posters here have speculated that Akida might be involved in something, it will likely end up having been a competitor. The irony is the excitement generated by this speculation has helped to inflate the share price, where in reality it should actually be lowering it.

- The fact some posters here like to present BRN as having no competition, and get triggered when anyone mentions the “competitor” word, should be a big red flag

- In my view, BRN’s share price has been inflated, at least in part, by gullible and vulnerable people falling for the wild speculation posted on BrainChip Facebook groups, reddit, HC posts, telegram messages etc. In my opinion, this had resulted in significant FOMO which has manifested in the recent price action.

- The fact many BRN bulls were triggered into meltdown by a single news article that raised some issues re BRN, suggests to me:
1. posters here are far less confident in Akida than they let on;
2. contrary to what they claim, many posters here are not long term holders, as otherwise it is hard to see why they were so triggered by a single article! At the end of the day, if Akida is as good as they all claim, this article is totally irrelevant to the long term success of BRN which will be determined largely by the success of the technology itself. The fact so many posters were triggered, suggests many are in fact traders and feel the share price can only be propped up by suppressing or boycotting any view that does not support the "BRN will be worth 10x Microsoft" narrative.

Expand

”BRN’s share price has been inflated, at least in part, by gullible and vulnerable people falling for the wild speculation posted on BrainChip Facebook groups, reddit, HC posts, telegram messages etc”

100%

No.	Vol.	Price($)
5	71948	20.0¢

No.

Vol.

Price($)

71948

20.0¢

Price($)	Vol.	No.
20.5¢	644737	16

Price($)

Vol.

No.

20.5¢

644737

No.	Vol.	Price($)
5	71948	0.200
37	1819808	0.195
44	2212675	0.190
62	2281453	0.185
61	1862290	0.180

No.

Vol.

Price($)

71948

0.200

1819808

0.195

2212675

0.190

2281453

0.185

1862290

0.180

Price($)	Vol.	No.
0.205	644737	16
0.210	988969	14
0.215	362171	9
0.220	1002314	26
0.225	453731	11

Price($)

Vol.

No.

0.205

644737

0.210

988969

0.215

362171

0.220

1002314

0.225

453731

(20min delay)
Last 20.0¢		Change -0.005(2.44%)		Mkt cap ! $371.1M

Open	High	Low	Value	Volume
20.5¢	20.5¢	19.5¢	$843.2K	4.220M

”BRN’s share price has been inflated, at least in part, by...

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Opyl forms JV with UK and US consortium to bring products to the world

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Geochemical work at Newington picks up gold and copper anomalies for Midas

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

”BRN’s share price has been inflated, at least in part, by...

Top Stories

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Opyl forms JV with UK and US consortium to bring products to the world

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Geochemical work at Newington picks up gold and copper anomalies for Midas

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News